Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed2
Recruiting1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT05304858Recruiting
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Recurrent Prostate Cancer
PrincipalinvestigatorStart date: 2021-09-15
NCT05077098Phase 1Completed
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer
Recurrent Prostate Cancer
PrincipalinvestigatorStart date: 2021-08-12
NCT03951831Phase 2Active Not Recruiting
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
Prostate Cancer Metastatic
PrincipalinvestigatorStart date: 2019-05-16
NCT03689699Phase 1/2Completed
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
Adenocarcinoma of the ProstateProstate Cancer
PrincipalinvestigatorStart date: 2018-10-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05304858PrincipalInvestigator

Tumor Microenvironment Analysis of Prostate Cancer Metastasis

Recurrent Prostate Cancer
Recruiting
NCT05077098Phase 1PrincipalInvestigator

Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Recurrent Prostate Cancer
Completed
NCT03951831Phase 2PrincipalInvestigator

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

Prostate Cancer Metastatic
Active Not Recruiting
NCT03689699Phase 1/2PrincipalInvestigator

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Adenocarcinoma of the ProstateProstate Cancer
Completed

All 4 trials loaded